Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS-8958 Clinical Pharmacology Study
jRCT2080222944Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of laninamivir octanoate in influenza (4 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Pharmacokinetics of CS-8958 and laninamivir, Pulmonary retention of laninamivir and 1 more. Started Aug 2015; status: completed.
02
Drugs
laninamivir octanoate
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080222944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222944.